Literature DB >> 10381636

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.

A D Badley1, K Parato, D W Cameron, S Kravcik, B N Phenix, D Ashby, A Kumar, D H Lynch, J Tschopp, J B Angel.   

Abstract

T cells from HIV infected patients undergo spontaneous apoptosis at a faster rate than those from uninfected patients, are abnormally susceptible to activation induced cell death (AICD), and undergo increased apoptosis in response to Fas receptor ligation. These observations have led to the hypothesis CD4 T cell apoptosis may be a mechanism of CD4 T cell depletion and the pathogenesis of AIDS. Successful treatment of HIV infected patients is accompanied by quantitative and qualitative improvements in immune function reflecting at least partial reversibility of the underlying pathogenesis of HIV. In this report we correlate improvements in markers of immune function with a decrease in apoptosis, and changes in its regulation. Therapy with nelfinavir plus saquinavir in combination with two nucleoside analogue inhibitors of reverse transcriptase dramatically reduces plasma viremia and increases CD4 T cell counts. Coincident with these improvements, CD38 and HLA-DR coexpression on both CD4 and CD8 T cells decrease, and CD45RA and CD62L coexpression increase. Furthermore, spontaneous apoptosis decreases in both CD4 and CD8 T cells (CD4 apoptosis 17.4 vs 2.6%, P=0.005; CD8 apoptosis 15.0 vs 1.0%, P<0.001), as does both Fas mediated apoptosis (CD4 apoptosis 19.0 vs 3.5%, P=0.03; CD8 apoptosis 13.7 vs 1.5%, P=0.002) and CD3 induced AICD (CD4 apoptosis 13.7 vs 3.2%, P=0.001; CD8 apoptosis 29 vs 2.2%, P=0.08). Changes in apoptosis are not associated with changes in Fas receptor expression, but are significantly correlated with changes in activation marker profiles. Although this suggests a possible regulatory role for the apoptosis inhibitory protein FLIP, direct assessment did not reveal quantitative differences in FLIP expression between apoptosis resistant PBL's from HIV negative patients, and apoptosis sensitive PBL's from HIV positive patients. These findings support the hypothesis that apoptosis mediates HIV induced CD4 T cell depletion, but indicate the need for further studies into the molecular regulation of HIV induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381636     DOI: 10.1038/sj.cdd.4400509

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  29 in total

Review 1.  Mitochondria and apoptosis: HQ or high-security prison?

Authors:  N J Waterhouse; D R Green
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  Role of antiretroviral regimes in HIV-1 patients in reducing immune activation.

Authors:  Antonio Jiménez; Laura Molero; Ana Jiménez; Susana Castañón; Dolores Subirá; Miguel De Górgolas; Manuel Fedz-Guerrero; Rosa García
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

3.  Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection.

Authors:  Enrique Espinosa; Christopher E Ormsby; Gustavo Reyes-Terán; Robert Asaad; Scott F Sieg; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

4.  Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis.

Authors:  Julian J Lum; Oren J Cohen; Zilin Nie; Joel G Weaver; Timothy S Gomez; Xiao-Jian Yao; David Lynch; André A Pilon; Nanci Hawley; John E Kim; Zhaoxia Chen; Michael Montpetit; Jaime Sanchez-Dardon; Eric A Cohen; Andrew D Badley
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 5.  HIV protease inhibitors impact on apoptosis.

Authors:  Stacey A Rizza; Andrew D Badley
Journal:  Med Chem       Date:  2008-01       Impact factor: 2.745

Review 6.  Nelfinavir: an update on its use in HIV infection.

Authors:  A Bardsley-Elliot; G L Plosker
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

7.  Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling.

Authors:  R Roggero; V Robert-Hebmann; S Harrington; J Roland; L Vergne; S Jaleco; C Devaux; M Biard-Piechaczyk
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.

Authors:  Zhenwu Luo; Lei Ma; Lumin Zhang; Lisa Martin; Zhuang Wan; Stephanie Warth; Andrew Kilby; Yong Gao; Pallavi Bhargava; Zhen Li; Hao Wu; Eric G Meissner; Zihai Li; J Michael Kilby; Guoyang Liao; Wei Jiang
Journal:  Vaccine       Date:  2015-12-22       Impact factor: 3.641

9.  Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates.

Authors:  Carole Elbim; Valerie Monceaux; Yvonne M Mueller; Mark G Lewis; Stephanie François; Ousmane Diop; Khadija Akarid; Bruno Hurtrel; Marie-Anne Gougerot-Pocidalo; Yves Lévy; Peter D Katsikis; Jerome Estaquier
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

10.  Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model.

Authors:  Patrick M Younan; Patricia Polacino; John P Kowalski; Christopher W Peterson; Nicholas J Maurice; Nathaniel P Williams; On Ho; Grant D Trobridge; Dorothee Von Laer; Martin Prlic; Brian C Beard; Stephen DeRosa; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.